A MAJOR ROLE FOR CYTOCHROME P450TB (CYP2C SUBFAMILY) IN THE ACTIONS OF NONSTEROIDAL ANTIIFLAMMATORY DRUGS

被引:0
|
作者
LEEMANN, TD [1 ]
TRANSON, C [1 ]
BONNABRY, P [1 ]
DAYER, P [1 ]
机构
[1] UNIV GENEVA,HOP CANTONAL,DEPT MED,PAIN CLIN,CH-1211 GENEVA 4,SWITZERLAND
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Most non-steroidal antiinflammatory drugs (NSAIDs) are extensively metabolized by liver oxidation with broad interindividual variability, but little is known about the nature of the enzyme(s) catalysing these reactions. The role of specific cytochrome P450 isozymes in the formation of the major oxidized metabolites of phenylacetic acid (diclofenac), propionic acid (ibuprofen), fenamate (mefenamic acid) and oxicam (piroxicam and tenoxicam) derivatives was studied in human liver microsomes using mostly selective inhibition by known substrates and inhibitors of specific cytochrome P450 monooxygenases. A common isozyme (P450TB, CYP2C subfamily) controls the major elimination pathways of these NSAIDs. The authors have also determined, in two in vitro models of P450TB activity, the affinity for this isozyme of other NSAIDs (acetylsalicylic acid, indomethacin, pirprofen). The NSAIDs tested displayed a high affinity (5-500 mu M): diclofenac approximate to mefenamic acid > ibuprofen approximate to indomethacin approximate to piroxicam approximate to tenoxicam > acetylsalicylic acid approximate to pirprofen. Cytochrome P450TB therefore plays a key role in the oxidation by human liver of major NSAIDs from various chemical classes. Inhibition data and chemical structure similarities suggest that many other NSAIDs may be substrates of this isozyme as well. P450TB appears to be a common site both for the control of interindividual differences in the capacity to oxidize major NSAIDs and for interactions involving NSAIDs as well as other known substrates (oral anticoagulants, hypoglycaemic sulfonylureas, phenytoin) or inhibitors (antifungals, antibacterial sulfonamides, calcium channel blockers) of P450TB. Consequently this P450 isozyme is likely to be a major determinant of NSAIDs action.
引用
收藏
页码:189 / 195
页数:7
相关论文
共 50 条
  • [21] Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10
    Robert Walton
    Martin Kimber
    Kirk Rockett
    Clare Trafford
    Dominic Kwiatkowski
    Giorgio Sirugo
    Nature Genetics, 2005, 37 : 915 - 916
  • [22] CDNA AND DEDUCED AMINO-ACID-SEQUENCE OF A DWARF GOAT LIVER CYTOCHROME-P450 FRAGMENT BELONGING TO THE CYP2C GENE SUBFAMILY
    ZEILMAKER, WM
    VANTKLOOSTER, GAE
    GREMMELSGEHRMANN, JF
    VANMIERT, ASJPAM
    HORBACH, GJMJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) : 120 - 125
  • [23] Impact of genetic polymorphisms of cytochrome P450 2 C (CYP2C) enzymes on the drug metabolism and design of antidiabetics
    Sun, Hao
    Scott, Dennis O.
    CHEMICO-BIOLOGICAL INTERACTIONS, 2011, 194 (2-3) : 159 - 167
  • [24] 6-BASE DELETION OCCURRING IN MESSAGES OF HUMAN CYTOCHROME-P-450 IN THE CYP2C SUBFAMILY RESULTS IN REDUCTION OF TOLBUTAMIDE HYDROXYLASE-ACTIVITY
    OHGIYA, S
    KOMORI, M
    OHI, H
    SHIRAMATSU, K
    SHINRIKI, N
    KAMATAKI, T
    BIOCHEMISTRY INTERNATIONAL, 1992, 27 (06): : 1073 - 1081
  • [25] Reply to 'Haplotype block structure of the cytochrome P450 CYP2C gene cluster on chromosome 10'
    Kourosh R Ahmadi
    Michael E Weale
    Allen D Roses
    Ann M Saunders
    David B Goldstein
    Nature Genetics, 2005, 37 : 916 - 916
  • [26] Hepatic cytochrome P450 CYP2C activity in psoriasis: Studies using proguanil as a probe compound
    Helsby, NA
    Ward, SA
    Parslew, RAG
    Friedmann, PS
    Rhodes, LE
    ACTA DERMATO-VENEREOLOGICA, 1998, 78 (02) : 81 - 83
  • [27] Metabolic interactions of magnolol with cytochrome P450 enzymes: uncompetitive inhibition of CYP1A and competitive inhibition of CYP2C
    Kim, Sang-Bum
    Kang, Hee Eun
    Cho, Hyun-Jong
    Kim, Yeong Shik
    Chung, Suk-Jae
    Yoon, In-Soo
    Kim, Dae-Duk
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2016, 42 (02) : 263 - 269
  • [28] Ethanol oxidation into acetaldehyde by 16 recombinant human cytochrome P450 isoforms: Role of CYP2C isoforms in human liver microsomes
    Hamitouche, S.
    Poupon, J.
    Dreano, Y.
    Amet, Y.
    Lucas, D.
    TOXICOLOGY LETTERS, 2006, 167 (03) : 221 - 230
  • [29] Generation and Characterization of Novel Cytochrome P450 Cyp2c Gene Cluster Knockout and CYP2C9 Humanized Mouse Lines
    Scheer, Nico
    Kapelyukh, Yury
    Chatham, Lynsey
    Rode, Anja
    Buechel, Sandra
    Wolf, C. Roland
    MOLECULAR PHARMACOLOGY, 2012, 82 (06) : 1022 - 1029
  • [30] Cytochrome P450 epoxygenases and vascular tone: novel role for HMG-CoA reductase inhibitors in the regulation of CYP2C expression
    Fisslthaler, B
    Michaelis, UR
    Randriamboavonjy, V
    Busse, R
    Fleming, I
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2003, 1619 (03): : 332 - 339